ReciBioPharm, the advanced biologics division of Recipharm and a leading CDMO, has extended its long-standing partnership with the University of Oxford to support the clinical development of two malaria vaccine candidates, R78C and RH5.1. The collaboration builds on a relationship
ReciBioPharm, a leading Contract Development and Manufacturing Organisation (CDMO) has announced receiving a three-year grant from the Bill & Melinda Gates Foundation. The funding will support the development and deployment of xRNA Continuous Manufacturing technologies, focusing on low- and middle-income
LenioBio, a company specialising in cell-free protein expression technology, has entered a collaboration with ReciBioPharm, a contract development and manufacturing organisation (CDMO), to scale protein manufacturing and accelerate vaccine production. This partnership is part of an expansion of LenioBio’s CEPI-funded
ReciBioPharm, a provider of advanced therapeutics contract manufacturing services, and Hongene Biotech Corporation, known for its expertise in nucleic acid manufacturing, have announced a strategic collaboration aimed at improving gene editing drug manufacturing. This partnership will see ReciBioPharm expand its
